✦ LIBER ✦

Rituximab treatment in lupus nephritis - where do we stand?

✍ Scribed by Gunnarsson, I.; Jonsdottir, T.

Book ID: 121396694
Publisher: SAGE Publications
Year: 2013
Tongue: English
Weight: 129 KB
Volume: 22
Category: Article
ISSN: 0961-2033
DOI: 10.1177/0961203312471574

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chickenpox: Where do we stand with treat

Chickenpox: Where do we stand with treatment?

✍ Richard J. Whitley 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Treatment of hyperlipidemias: Where do w

Treatment of hyperlipidemias: Where do we stand?

✍ Richard J. Havel 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 514 KB

Type I interferon blockade in systemic l

Type I interferon blockade in systemic lupus erythematosus: where do we stand?

✍ Lauwerys, B. R.; Ducreux, J.; Houssiau, F. A. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 411 KB

Chemotherapeutic adjuvant treatment for

Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

✍ Jakob K. Anninga; Hans Gelderblom; Marta Fiocco; Judith R. Kroep; Antoni H.M. Ta 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 507 KB

Chemotherapeutic adjuvant treatment for

Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

✍ Jakob K. Anninga; Hans Gelderblom; Marta Fiocco; Judith R. Kroep; Antoni H.M. Ta 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 507 KB

## Aim: Since the introduction of chemotherapy, survival in localised high-grade osteosarcoma has improved considerably. however, there is still no worldwide consensus on a standard chemotherapy approach. in this systematic review evidence for effectiveness of each single drug and the role of respo

Household stockholding in Europe: where

Household stockholding in Europe: where do we stand and where do we go?

✍ Luigi Guiso; Michael Haliassos; Tullio Jappelli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB